Skip to main content

and
  1. No Access

    Article

    Localization of gelatinase activities in glioma tissues by film in situ zymography

    Malignant gliomas are characterized by their invasiveness and angiogenesis, which are mediated by metalloproteinases (MMPs). In this study, localization of gelatinase activities in six cases of glioblastoma, t...

    Shingo Takano, Koji Tsuboi, Akira Matsumura, Hiroshige Sato in Brain Tumor Pathology (2001)

  2. No Access

    Article

    Angiogenesis and antiangiogenic therapy for malignant gliomas

    Angiogenesis is crucial to the growth of malignant gliomas. Therefore, antiangiogenic therapy represents a new, promising therapeutic modality for malignant gliomas. This study was designed to define the malig...

    Shingo Takano, Hiroshi Kamiyama, Koji Tsuboi, Akira Matsumura in Brain Tumor Pathology (2004)

  3. No Access

    Article

    Detection of failure of bevacizumab treatment for malignant glioma based on urinary matrix metalloproteinase activity

    Although antiangiogenic treatment for malignant glioma using bevacizumab in combination with irinotecan chemotherapy has a promising effect on survival, the high incidence of increasing infiltrative tumors can...

    Shingo Takano, Ryota Mashiko, Satoru Osuka, Eiichi Ishikawa in Brain Tumor Pathology (2010)

  4. No Access

    Article

    Epileptogenic glioma in a 4-year-old child: a case report

    We report a rare case of epileptogenic glioma composed of glial progenitor cells that differentiated into an astrocytic and oligodendrocytic tumor. This 4-year-old girl presented with a 1-year history of compl...

    Ai Muroi, Shingo Takano, Kaishi Satomi, Akira Matsumura in Brain Tumor Pathology (2010)

  5. No Access

    Chapter

    Malignant Brain Tumors: Role of Radioresponsive Gene Therapy

    Patients with malignant gliomas have a very poor prognosis. To explore a novel and more effective approach for the treatment of malignant gliomas, a strategy combining suicide gene therapy and radiation treatm...

    Hideo Tsurushima, Akira Matsumura in Tumors of the Central Nervous system, Volume 3 (2011)

  6. Article

    Erratum to: Detection of IDH1 mutation in human gliomas: comparison of immunohistochemistry and sequencing

    Shingo Takano, Wei Tian, Masahide Matsuda, Tetsuya Yamamoto in Brain Tumor Pathology (2011)

  7. No Access

    Article

    Detection of IDH1 mutation in human gliomas: comparison of immunohistochemistry and sequencing

    Isocitrate dehydrogenase 1 (IDH1) mutations have recently been identified as early and frequent genetic alterations in astrocytomas, oligodendrogliomas, and oligoastrocytomas, as well as secondary glioblastoma...

    Shingo Takano, Wei Tian, Masahide Matsuda, Tetsuya Yamamoto in Brain Tumor Pathology (2011)

  8. No Access

    Article

    Benign spinal meningioma without dural attachment presenting delayed CSF dissemination and malignant transformation

    Benign spinal meningiomas have good prognoses, with low rates of recurrence and no cerebrospinal fluid (CSF) dissemination. However, we experienced an extremely rare case of initially benign non-dura-based spi...

    Kyoji Tsuda, Hiroyoshi Akutsu, Tetsuya Yamamoto, Eiichi Ishikawa in Brain Tumor Pathology (2013)

  9. Article

    Preface to special edition

    Akira Matsumura in Brain Tumor Pathology (2014)

  10. No Access

    Article

    Intraoperative pathological diagnosis in 205 glioma patients in the pre-BCNU wafer era: retrospective analysis with intraoperative implantation of BCNU wafers in mind

    The present retrospective data analysis was performed to determine whether intraoperative pathological diagnosis (IOD) using frozen section (FS) could clearly distinguish high-grade glioma from WHO grade II gl...

    Eiichi Ishikawa, Tetsuya Yamamoto, Kaishi Satomi, Masahide Matsuda in Brain Tumor Pathology (2014)

  11. No Access

    Article

    Comparison of magnetic resonance imaging with invasive histological findings of Langerhans cell histiocytosis

    Due to the rarity of skull Langerhans cell histiocytosis (LCH), correlations between abnormalities on magnetic resonance imaging (MRI) and pathological findings have not been fully evaluated. Only a few report...

    Shinya Watanabe, Tetsuya Yamamoto, Kaishi Satomi, Masahide Matsuda in Brain Tumor Pathology (2014)

  12. No Access

    Article

    Diagnostic advantage of double immunohistochemistry using two mutation-specific anti-IDH antibodies (HMab-1 and MsMab-1) in gliomas

    Isocitrate dehydrogenase (IDH) mutation is a valuable prognostic marker and a tool for decision-making for glioma treatment. An algorithm for IDH mutation screening was recently proposed—it consists of a two-s...

    Shingo Takano, Yukinari Kato, Tetsuya Yamamoto, **ng Liu in Brain Tumor Pathology (2015)

  13. No Access

    Article

    Rosette-forming glioneuronal tumor originating in the hypothalamus

    Rosette-forming glioneuronal tumors (RGNT) of the fourth ventricle are slow-growing tumors that primarily involve the fourth ventricular region. We here report the first patient, an 8-year-old girl, with an RG...

    Tetsuya Yamamoto, Teppei Matsubara, Kaishi Satomi in Brain Tumor Pathology (2015)

  14. No Access

    Article

    Immunohistochemistry on IDH 1/2, ATRX, p53 and Ki-67 substitute molecular genetic testing and predict patient prognosis in grade III adult diffuse gliomas

    The molecular subgrou** of diffuse gliomas was recently found to stratify patients into prognostically distinct groups better than histological classification. Among several molecular parameters, the key mol...

    Shingo Takano, Eiichi Ishikawa, Noriaki Sakamoto, Masahide Matsuda in Brain Tumor Pathology (2016)

  15. No Access

    Article

    Infiltration of CD163-positive macrophages in glioma tissues after treatment with anti-PD-L1 antibody and role of PI3Kγ inhibitor as a combination therapy with anti-PD-L1 antibody in in vivo model using temozolomide-resistant murine glioma-initiating cells

    Although chemoimmunotherapy often lengthens glioblastoma (GBM) survival, early relapses remain problematic as immunosuppressive M2 macrophages (Mϕ) that function via inhibitory cytokine and PD-L1 production ca...

    Tsubasa Miyazaki, Eiichi Ishikawa, Masahide Matsuda, Narushi Sugii in Brain Tumor Pathology (2020)

  16. No Access

    Article

    Highly sensitive detection of TERT promoter mutations in recurrent glioblastomas using digital PCR

    Telomerase reverse transcriptase promoter (TERTp) hotspot mutations are the most frequent mutations in primary glioblastomas (GBM). Previous studies have shown that the combination of TERTp and isocitrate dehydro...

    Shunichiro Miki, Kaishi Satomi, Makoto Ohno, Yuko Matsushita in Brain Tumor Pathology (2020)